KF
EXAS

Krilogy Financial’s Exact Sciences EXAS Stock Holding History

Krilogy Financial’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-34,910
Closed -$3.58M – 1004
2025
Q4 		$3.58M Sell
34,910
-20,935
-37% -$1.68M 0.12% 141
2025
Q3 		$3.89M Buy
55,845
+13,129
+31% +$656K 0.15% 119
2025
Q2 		$2.27M Sell
42,716
-8,147
-16% -$414K 0.13% 126
2025
Q1 		$2.2M Buy
50,863
+29,636
+140% +$1.5M 0.14% 121
2024
Q4 		$1.19M Sell
21,227
-3,556
-14% -$221K 0.08% 152
2024
Q3 		$1.69M Sell
24,783
-5,982
-19% -$338K 0.12% 131
2024
Q2 		$1.3M Buy
30,765
+3,851
+14% +$212K 0.1% 145
2024
Q1 		$1.86M Buy
26,914
+7,340
+37% +$464K 0.14% 127
2023
Q4 		$1.45M Sell
19,574
-2,800
-13% -$184K 0.12% 126
2023
Q3 		$1.53M Buy
22,374
+10,215
+84% +$867K 0.14% 127
2023
Q2 		$1.14M Sell
12,159
-5,956
-33% -$465K 0.1% 142
2023
Q1 		$1.23M Buy
18,115
+5,696
+46% +$366K 0.1% 162
2022
Q4 		$615K Sell
12,419
-4,952
-29% -$202K 0.06% 225
2022
Q3 		$564K Sell
17,371
-1
-0% -$41 0.07% 186
2022
Q2 		$684K Buy
17,372
+13,139
+310% +$703K 0.08% 170
2022
Q1 		$296K Sell
4,233
-10,825
-72% -$791K 0.03% 251
2021
Q4 		$1.17M Buy
15,058
+4,880
+48% +$431K 0.12% 118
2021
Q3 		$971K Buy
10,178
+707
+7% +$74.6K 0.1% 135
2021
Q2 		$1.18M Buy
9,471
+228
+2% +$27.2K 0.12% 120
2021
Q1 		$1.22M Buy
9,243
+511
+6% +$69.9K 0.13% 106
2020
Q4 		$1.16M Sell
8,732
-118
-1% -$14.3K 0.14% 96
2020
Q3 		$902K Sell
8,850
-102
-1% -$8.81K 0.13% 116
2020
Q2 		$778K Sell
8,952
-11,691
-57% -$934K 0.12% 116
2020
Q1 		$1.2M Buy
+20,643
New +$1.68M 0.23% 69
2018
Q4 		– Sell
-200
Closed -$16K – 300
2018
Q3 		$16K Buy
+200
New +$13K ﹤0.01% 461
2018
Q2 		– Sell
-1,700
Closed -$69K – 303
2018
Q1 		$69K Buy
1,700
+400
+31% +$19.5K 0.02% 285
2017
Q4 		$68K Buy
1,300
+100
+8% +$5.34K 0.02% 281
2017
Q3 		$57K Sell
1,200
-2,700
-69% -$109K 0.01% 321
2017
Q2 		$138K Buy
3,900
+3,650
+1,460% +$113K 0.04% 176
2017
Q1 		$3K Hold
250
– – ﹤0.01% 619
2016
Q4 		$3K Hold
250
– – ﹤0.01% 619
2016
Q3 		$5K Hold
250
– – ﹤0.01% 593
2016
Q2 		$3K Hold
250
– – ﹤0.01% 649
2016
Q1 		$2K Hold
250
– – ﹤0.01% 601
2015
Q4 		$2K Buy
+250
New +$2.33K ﹤0.01% 378

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.68B AUM 31.18% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Krilogy Financial's EXAS Position: Q1 2026 in Review

Krilogy Financial sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 34,910 shares — an estimated $3.58M sold.

Krilogy Financial first reported a position in EXAS in Q4 2015 and held it in 35 quarters. The position peaked at $3.89M in Q3 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Krilogy Financial reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Krilogy Financial sold 34,910 Exact Sciences shares in Q1 2026, an estimated $3.58M.
  • Krilogy Financial first reported a position in Exact Sciences in Q4 2015 and held it in 35 quarters.
  • Krilogy Financial's Exact Sciences position peaked at $3.89M in Q3 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Krilogy Financial's 13F filing for Q1 2026, filed 17 Apr 2026.